RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human colon carcinoma xenograft in nude mice

Journal of Biomedical Nanotechnology

Volumn 6, Issue 3, 2010, Pages 272-278

  Lei, Ke ^a   Ye, Lu ^a   Yang, Yang ^a   Wang, Guan Jie ^a   Jiang, Qing Yuan ^a   Jiang, Yu ^a   Wei, Yu Quan ^a   Deng, Hong Xin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; Colon carcinoma; Focal Adhesion Kinase (FAK); RNA interference

Indexed keywords

ANGIOGENESIS; APOPTOSIS INDUCTION; CATIONIC LIPOSOMES; COLON CARCINOMA; CONTROL GROUPS; FOCAL ADHESION KINASE; HUMAN COLON; HUMAN COLON CANCER; HUMAN COLON CANCER CELLS; IMMUNOHISTOCHEMISTRY; IN-VITRO; NUDE MICE; PLASMID ENCODING; PROLIFERATING CELL NUCLEAR ANTIGENS; RNA INTERFERENCE; SHORT HAIRPIN RNA (SHRNA); SIDE EFFECT; TAIL VEINS; TUMOR GROWTH; TUMOR VOLUMES; TUMOR XENOGRAFTS; TUNEL ASSAY;

ADHESION; BIOLOGICAL MATERIALS; CELL PROLIFERATION; ENCODING (SYMBOLS); ENZYMES; MAMMALS; RNA; TUMORS;

CELL DEATH;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CD31 ANTIGEN; CHOLESTEROL; CYCLINE; FOCAL ADHESION KINASE; LIPOPLEX; SHORT HAIRPIN RNA; FOCAL ADHESION KINASE 1; PTK2 PROTEIN, HUMAN; RNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; COLON CARCINOMA; ENCAPSULATION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA INTERFERENCE; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; COLON TUMOR; GENE THERAPY; GENETICS; METHODOLOGY; NUDE MOUSE; TREATMENT OUTCOME;

ANIMALS; COLONIC NEOPLASMS; FOCAL ADHESION KINASE 1; GENE THERAPY; MICE; MICE, NUDE; RNA; RNA INTERFERENCE; TREATMENT OUTCOME;

EID: 79952200970     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2010.1127     Document Type: Article

References (40)

1. C. G. Moertel, T. R. Fleming, J. S. Macdonald, D. G. Haller, J. A. Laurie, C. M. Tangen, J. S. Ungerleider, W. A. Emerson, D. C. Tormey, J. H. Glick, M. H. Veeder, and J. A. Mailliard, Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report. Ann. Intern. Med. 122, 321 (1995).
2. T. Andre, E. Quinaux, C. Louvet, P. Colin, E. Gamelin, O. Bouche, E. Achille, P. Piedbois, N. Tubiana-Mathieu, A. Boutan-Laroze, M. Flesch, G. Lledo, Y. Raoul, I. Debrix, M. Buyse, and A. De Gramont, Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: Final results of GERCOR C96.1. J. Clin. Oncol. 25, 3732 (2007).
3. D. I. Obrand and P. H. Gordon, Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis. Colon. Rectum. 40, 15 (1997).
4. V. Gabarra-Niecko, M. D. Schaller, and J. M. Dunty, FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev. 22, 359 (2003).
5. M. J. Van Nimwegen, M. Huigsloot, A. Camier, I. B. Tijdens, and B. Van De Water, Focal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells. Mol. Pharmacol 70, 1330 (2006).
6. M. J. Van Nimwegen and B. Van De Water, Focal adhesion kinase: A potential target in cancer therapy. Biochem. Pharmacol. 73, 597 (2007).
7. A. L. Lark, C. A. Livasy, B. Calvo, L. Caskey, D. T. Moore, X. Yang, and W. G. Canee, Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: Immunohistochemistry and real-time PCR analyses. Clin. Cancer Res. 9, 215 (2003).
8. M. C. Maa, J. C. Lee, Y. J. Chen, Y. J. Chen, Y. C. Lee, S. T. Wang, C. C. Huang, N. H. Chow, and T. H. Leu, Eps8 facilitates cellular growth and motility of colon cancer cells by increasing the expression and activity of focal adhesion kinase. J. Biol. Chem. 282, 19399 (2007).
9. G. Baillat, C. Siret, E. Delamarre, and J. Luis, Early adhesion induces interaction of FAK and Fyn in lipid domains and activates raft-dependent Akt signaling in SW480 colon cancer cells. Biochim. Biophys. Acta. 1783, 2323 (2008).
10. S. Van Slambrouck, C. Grijelmo, O. De Wever, E. Bruyneel, S. Emami, C. Gespach, and W. F. Steelant, Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion. Int. J. Oncol. 31, 1501 (2007).
11. M. S. Ridyard and E. J. Sanders, Inhibition of focal adhesion kinase expression correlates with changes in the cytoskeleton but not apoptosis in primary cultures of chick embryo cells. Cell Biol. Int. 25, 215 (2001).
12. L. H. Xu, L. V. Owens, G. C. Sturge, X. Yang, E. T. Liu, R. J. Craven, and W. G. Canee, Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ. 7, 413 (1996).
13. M. D. Schaller, C. A. Borgman, and J. T. Parsons, Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol. Cell Biol. 13, 785 (1993).
14. Y. Zhao, L. J. Zhao, L. J. Zhou, Y. Zhi, J. M. Xu, Z. Wei, K. X. Zhang, B. F. Ouellette, and H. B. Shen, Quantum dot conjugates for targeted silencing of Bcr/Abl gene by RNA interference in human myelogenous leukemia K562 cells. J. Nanosci. Nanotechnol. 10, 5137 (2010).
15. M. A. Mcanuff, G. R. Rettig, and K. G. Rice, Potency of siRNA versus shRNA mediated knockdown in vivo. J. Pharm. Sci. 96, 2922 (2007).
16. A. P. Mccaffrey, L. Meuse, T. T. Pham, D. S. Conklin, G. J. Hannon, and M. A. Kay, RNA interference in adult mice. Nature 418, 38 (2002).
17. W. Yang, J. Fu, T. Wang, and N. He, Chitosan/sodium tripolyphosphate nanoparticles: Preparation, characterization and application as drug carrier. J. Biomed. Nanotechnol. 5, 591 (2009).
18. O. Mykhaylyk, A. Steingotter, H. Perea, J. Aigner, R. Botnar, and C. Plank, Nucleic acid delivery to magnetically-labeled cells in a 2D array and at the luminal surface of cell culture tube and their detection by MRI. J. Biomed. Nanotechnol. 5, 692 (2009).
19. E. Jager, C. G. Venturini, F. S. Poletto, L. M. Colome, J. P. Pohlmann, A. Bernardi, A. M. Battastini, S. S. Guterres, and A. R. Pohlmann, Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area. J. Biomed. Nanotechnol. 5, 130 (2009).
20. A. Arkhis, A. Elaissari, T. Delair, B. Verrier, and B. Mandrand, Capture of enveloped viruses using polymer tentacles containing magnetic latex particles. J. Biomed. Nanotechnol. 6, 28 (2010).
21. A. M. Krieg, T. Wu, R. Weeratna, S. M. Efler, L. Love-Homan, L. Yang, A. K. Yi, D. Short, and H. L. Davis, Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA 95, 12631 (1998).
22. Y. Q. Wei, M. J. Huang, L. Yang, X. Zhao, L. Tian, Y. Lu, J. M. Shu, C. J. Lu, T. Niu, B. Kang, Y. Q. Mao, F. Liu, Y. J. Wen, S. Lei, F. Luo, L. Q. Zhou, F. Peng, Y. Jiang, J. Y. Liu, H. Zhou, Q. R. Wang, Q. M. He, F. Xiao, Y. Y. Lou, X. J. Xie, Q. Li, Y. Wu, Z. Y. Ding, B. Hu, M. Hu, and W. Zhang, Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc. Natl. Acad. Sci. USA 98, 11545 (2001).
23. X. B. Du, J. Y. Lang, J. R. Xu, Y. Lu, Y. J. Wen, J. M. Zhao, P. Diao, Z. P. Yuan, B. Yao, L. Y. Fan, G. Q. Wang, L. Liu, Z. Y. Ding, Y. S. Wang, T. Li, R. Wang, Y. Q. Mao, B. Kan, H. B. Wu, H. X. Li, H. S. Yang, H. B. Wu, Y. Q. Wei, and X. Zhao, Vesicular stomatitis virus matrix protein gene enhances the antitumor effects of radiation via induction of apoptosis. Apoptosis 13, 1205 (2008).
24. M. D. Schaller, Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta. 1540, 1 (2001).
25. A. P. Gilmore and L. H. Romer, Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol. Biol. Cell. 7, 1209 (1996).
26. V. G. Brunton, B. W. Ozanne, C. Paraskeva, and M. C. Frame, A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer. Oncogene 14, 283 (1997).
27. S. K. Hanks and T. R. Polte, Signaling through focal adhesion kinase. Bioessays 19, 137 (1997).
28. R. W. Tilghman and J. T. Parsons, Focal adhesion kinase as a regulator of cell tension in the progression of cancer. Semin. Cancer Biol. 18, 45 (2008).
29. T. M. Weiner, E. T. Liu, R. J. Craven, and W. G. Cance, Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors. Ann. Surg. Oncol. 1, 18 (1994).
30. L. V. Owens, L. Xu, R. J. Craven, G. A. Dent, T. M. Weiner, L. Romberg, E. T. Liu, and W. G. Cance, Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55, 2752 (1995).
31. P. C. Chan, J. F. Lai, C. H. Cheng, M. J. Tang, C. C. Chiu, and H. C. Chen, Suppression of ultraviolet irradiation-induced apoptosis by overexpression of focal adhesion kinase in Madin-Darby canine kidney cells. J. Biol. Chem. 274, 26901 (1999).
32. Y. Sonoda, Y. Matsumoto, M. Funakoshi, D. Yamamoto, S. K. Hanks, and T. Kasahara, Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J. Biol. Chem. 275, 16309 (2000).
33. B. Van De Water, F. Houtepen, M. Huigsloot, and I. B. Tijdens, Suppression of chemically induced apoptosis but not necrosis of renal proximal tubular epithelial (LLC-PKI) cells by focal adhesion kinase (FAK). Role of FAK in maintaining focal adhesion organization after acute renal cell injury. J. Biol. Chem. 276, 36183 (2001).
34. M. S. Duxbury, H. Ito, E. Benoit, M. J. Zinner, S. W. Ashley, and E. E. Whang, RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem. Biophys. Res. Commun. 311, 786 (2003).
35. J. Halder, A. A. Kamat, C. N. Landen, Jr., L. Y. Han, S. K. Lutgendorf, Y. G. Lin, W. M. Merritt, N. B. Jennings, A. Chavez-Reyes, R. L. Coleman, D. M. Gershenson, R. Schmandt, S. W. Cole, G. Lopez-Berestein, and A. K. Sood, Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin. Cancer Res. 12, 4916 (2006).
36. A. M. Alaouie and S. Sofou, Liposomes with triggered content release for cancer therapy. J. Biomed. Nanotechnol. 4, 234 (2008).
37. D. Cun, L. B. Jensen, H. M. Nielsen, M. Moghimi, and C. Foged, Polymeric nanocarriers for siRNA delivery: Challenges and future prospects. J. Biomed. Nanotechnol. 4, 258 (2008).
38. D. Davis, U. Akhtar, B. Keaster, K. Grozinger, L. Washington, S. Kelsey, A. Sarkar, and R. K. Delong, Challenges and potential for RNA nanoparticles (RNPs). J. Biomed. Nanotechnol. 5, 36 (2009).
39. Y. C. Tseng and L. Huang, Self-assembled lipid nanomedicines for siRNA tumor targeting. J. Biomed. Nanotechnol. 5, 351 (2009).
40. J. T. Parsons, Focal adhesion kinase: The first ten years. J. Cell Sci. 116, 1409 (2003).